comparemela.com
Home
Live Updates
Xenon stock surges as B.C. biotechs epilepsy drug shows promise for treating depression : comparemela.com
Xenon stock surges as B.C. biotech's epilepsy drug shows promise for treating depression
Company co-founded by renowned geneticist Michael Hayden building franchise around treatment discovered by Valeant
Related Keywords
South Africa ,
United Kingdom ,
Madrid ,
Spain ,
University Of Cape Town ,
Western Cape ,
Netherlands ,
San Diego ,
California ,
United States ,
Canada ,
Germany ,
German ,
Dutch ,
British ,
Christopher Crean ,
Michael Hayden ,
Simon Pimstone ,
Tijana Martin ,
Ian Mortimer ,
Michael Pearson ,
David Martin ,
Andrew Tsai ,
Bernard Pimstone ,
Teva Pharmaceutical Industries Ltd ,
Valeant Pharmaceuticals International Inc ,
Xenon Pharmaceuticals Inc ,
University Of British Columbia ,
Centre For Molecular Medicine ,
Bausch Health Cos ,
Genentech Inc ,
Neurocrine Biosciences Inc ,
Canada Biovail Corp ,
Pearson ,
Mckinsey Co ,
Log Increate Free ,
Xenon Pharmaceuticals ,
British Columbia ,
German Holocaust ,
Second World ,
Molecular Medicine ,
Teva Pharmaceutical Industries ,
Valeant Pharmaceuticals International ,
Biovail Corp ,
Bausch Health ,
Bloom Burton ,
Montgomery Asberg Depression ,
Xenon ,
Drug ,
Xen1101 ,
Ezogabine ,
Company ,
Hayden ,
Stock ,
Laval ,
comparemela.com © 2020. All Rights Reserved.